americanpharmaceuticalreviewMarch 10, 2020
Tag: DCAT Week 2020 , COVID-19 , DCAT
The DCAT Board of Directors has released the following announcement regarding their planned event in March:
The DCAT organization has been following the situation around COVID-19 very closely. While we recognize and appreciate how important this event is to our member companies, out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
We recognize the challenges this may cause, and we apologize for the inconvenience; however, it is our responsibility to prioritize the health and safety of our member companies, attendees, employees and all of those who help with this week-long event. The cancellation is consistent with the values of the DCAT organization and the member companies it serves.
Register as Visitor to CPhI China 2020!
-----------------------------------------------------------------------
Editor's Note:
En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the articles,
please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: